Submit Manuscript  

Article Details


Palliative Care in High and Low Resource Countries

Author(s):

Rejin Kebudi*, Fatma Betul Cakir and Michael Silbermann  

Abstract:


Palliative Care (PC) is defined by the World Health Organization (WHO) as a support given by multiple disciplines in order to improve the quality of life of both patients and their caregivers, throughout the disease course, from diagnosis to end-of-life. PC aims to prevent and treat symptoms and side effects of the disease and its treatment. PC is well developed in most high income countries; however in most low income settings, where, approximately 80% of patients with cancer requiring PC care for advanced disease live, PC services are still uncommon. Health indicators monitoring global PC development are policy, education, use of medicines, service provision and professional activity. Globally PC development may be categorized as: Group 1 (no known hospice-PC activity), Group 2 (capacity-building activity), Groups 3a Isolated PC provided, 3b Generalized PC provided, 4a hospice-PC services at a stage of integration into regular service provision and 4b hospice-PC services at a stage of advanced integration into regular service provision. Spirituality is an essential element of patient-centered PC. The use of complementary and traditional medicine (CTM) in Middle Eastern countries is widespread. There are wide discrepancies in cancer care and PC in many regions in the world. The Individualized Care Planning and Coordination (ICPC) Model is designed to facilitate the advance care planning with continuity of all the measures like symptom control or emotional, social and spiritual care of both the patient and the family during the disease steps like relapse or end of life.

Keywords:

palliative care, pediatric palliative care, pain management, human development index, individualized care planning, coordination

Affiliation:

Istanbul University, Oncology Institute, Pediatric Hematology and Oncology, Istanbul, Bezmialem Vakif University, Pediatric Hematology and Oncology, Istanbul, Middle East Cancer Consortium, Executive Director, Haifa



Full Text Inquiry